Ostarine or RAD-140: what is the difference

Ostarine and RAD-140 are two of the most talked-about SARMs — selective androgen receptor modulators — marketed online to people seeking muscle growth with supposedly fewer side effects than anabolic steroids. The reality is more complicated and more concerning. The editorial team compares the two compounds, explains what research exists, clarifies their legal status in the UK, and sets out the serious safety issues that the marketing glosses over.

What SARMs are meant to be

SARMs are compounds designed to stimulate androgen receptors — the same receptors that testosterone acts on — but selectively, favouring muscle and bone over tissues such as the prostate. The theoretical appeal is obvious: the muscle-building effects of androgens with fewer of the androgenic drawbacks. This is the promise on which the entire SARM market rests.

Ostarine, also called MK-2866 or enobosarm, is one of the most studied SARMs, originally developed as a potential treatment for muscle wasting. RAD-140, or testolone, is a newer, more potent compound investigated in early research settings. Both act on the androgen receptor but differ in strength and profile.

Crucially, neither is an approved medicine. No SARM has completed the full path to approval for general use as a muscle-building drug. What exists is a mixture of early clinical research, animal data and a large, unregulated grey market selling products of uncertain content.

That gap between the elegant theory and the messy reality is the single most important thing to understand before comparing the two. The selectivity is relative, not absolute, and the human safety data are far from complete.

Ostarine (MK-2866) in brief

Ostarine is the better-characterised of the two. It was studied by a pharmaceutical company as a treatment for conditions involving muscle loss, and some clinical trials in that context reported gains in lean mass. These studies used defined doses in supervised settings and are the source of most reliable information about the compound.

In research, ostarine is considered relatively mild among SARMs, with effects on lean mass that are real but modest compared with anabolic steroids. Even so, trials documented meaningful side effects, including suppression of the body's own testosterone production and changes in liver and cholesterol markers.

Its development as a medicine ultimately did not lead to approval for muscle wasting. That history is instructive: a compound studied seriously by professionals, showing some effect, still did not clear the bar of benefit versus risk for general use.

Today ostarine circulates mainly through the supplement grey market, often mislabelled or sold as a "research chemical". It is also a well-known cause of failed anti-doping tests, sometimes through contaminated supplements taken unknowingly.

RAD-140 (testolone) in brief

RAD-140 is newer and, in preclinical studies, more potent than ostarine, binding strongly to the androgen receptor. It attracted interest in early research, including as a possible avenue in certain medical contexts, but human data are far more limited than for ostarine.

Because it is more potent, the plausible concern is that it also suppresses natural hormone production more strongly and may stress the liver and cardiovascular markers to a greater degree. The thinness of human safety data makes these risks harder to quantify, which is itself a reason for caution rather than reassurance.

The comparison is less a matter of "which is better" and more a matter of degree of uncertainty. Ostarine is better studied but still unapproved and not without harm; RAD-140 is stronger but far less understood in humans.

Neither has a safety profile that justifies the casual, self-directed use that online marketing encourages.

Shared safety concerns

Despite their differences, the two share the core hazards of the SARM class. The selectivity that makes them attractive in theory is incomplete in practice, so they still act like androgens in ways that cause harm.

The documented and plausible harms include:

• Hormonal suppression: both lower the body's own testosterone, with recovery not guaranteed.
• Liver injury: cases of drug-induced liver damage have been reported with SARMs.
• Cardiovascular markers: reductions in protective HDL cholesterol and other adverse changes.
• Unknown long-term effects: no long-term human safety data exist for muscle-building use.

Compounding all of this is product quality. Independent analyses have repeatedly found that products sold as SARMs often contain the wrong substance, the wrong dose, or undeclared ingredients including actual steroids. A buyer frequently does not know what they are taking at all.

This article deliberately gives no dosing or cycling information, because there is no established safe regimen and because the honest message is that the risks are not worth the uncertain, modest gains.

Legal status and the honest bottom line

In the UK, SARMs are not licensed medicines and cannot legally be sold for human consumption as supplements; they are frequently marketed as "research chemicals" to sidestep this, which does not make them safe or their sale legitimate. For athletes, both ostarine and RAD-140 are on the World Anti-Doping Agency prohibited list, and positive tests — sometimes from contaminated products — have ended careers.

The regulatory agencies in the UK, EU and US have issued warnings about SARMs, citing the risk of liver damage and other serious harms and the prevalence of mislabelled products. These are not fringe cautions; they reflect a genuine pattern of injury.

So the honest comparison ends in the same place for both compounds. Ostarine is milder and better studied; RAD-140 is stronger and less understood. But neither is an approved, quality-controlled medicine, both suppress natural hormones and threaten the liver and heart, and both carry the gamble of not knowing what is actually in the bottle.

For anyone pursuing muscle and strength, the reliable path remains unglamorous but real: progressive training, adequate protein and energy, sleep and patience. Readers may also find our articles on natural muscle-building, on protecting liver health, and on the realities of the supplement grey market useful further reading.

Conclusions of the editorial team

Ostarine and RAD-140 differ mainly in potency and in how much we know: ostarine is milder and more studied, RAD-140 stronger but barely tested in humans. In both cases the "selective, side-effect-free" promise does not survive contact with the evidence.

Both suppress the body's own testosterone, both have been linked to liver and cardiovascular harm, neither is an approved medicine, and both are prohibited in sport. On top of that, products sold as SARMs are frequently mislabelled.

The difference between them is far smaller than the gap between the marketing and reality. The sensible conclusion is to avoid both and to build progress through training, nutrition and recovery under, where needed, qualified guidance.

References

1. Dalton JT, Barnette KG, Bohl CE, et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function. J Cachexia Sarcopenia Muscle. 2011;2(3):153-161.
2. Van Wagoner RM, Eichner A, Bhasin S, et al. Chemical composition and labeling of substances marketed as SARMs and sold via the internet. JAMA. 2017;318(20):2004-2010.
3. Flores JE, Chitturi S, Walker S. Drug-induced liver injury by selective androgenic receptor modulators. Hepatol Commun. 2020;4(3):450-452.
4. Solomon ZJ, Mirabal JR, Mazur DJ, et al. Selective androgen receptor modulators: current knowledge and clinical applications. Sex Med Rev. 2019;7(1):84-94.
5. Efimenko IV, Valancy D, Dubin JM, Ramasamy R. Adverse effects and potential benefits among SARMs users: a cross-sectional survey. Int J Impot Res. 2022;34(7):757-761.
6. World Anti-Doping Agency. The Prohibited List. Montreal: WADA.